Twist Bioscience Corporation (TWST)

Revenue by Segment

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Synthetic DNA Products	376.57M	312.97M	245.11M	203.57M	132.33M
Total	376.57M	312.97M	245.11M	203.57M	132.33M

Revenue by Geography

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Americas	225.58M	193.88M	151.26M	122.47M	77.91M
Europe, Middle East and Africa (EMEA)	124.24M	92.57M	71.39M	62.08M	44.12M
Asia Pacific (APAC)	26.75M	26.52M	22.46M	19.01M	10.30M
Total	376.57M	312.97M	245.11M	203.57M	132.33M

Data Source: S&P Global Market Intelligence Last updated: Aug 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 9, 2026

Data Sources Report a data error